MIGDAL HAEMEK, Israel - May 9, 2017 - TowerJazz, (NASDAQ: TSEM), the global specialty foundry leader, today announced that its management will be presenting at a number of upcoming conferences during May 2017. These include the Jefferies Technology Group Investor Conference in Miami, the 17th Annual Oppenheimer Israeli Conference in Tel Aviv, Israel and the 14th Annual Craig-Hallum Institutional Investor Conference in Minneapolis.
The Jefferies Technology Group Investor Conference will take place at the Mandarin Oriental Hotel in Miami. TowerJazz's Senior Vice President and General Manager, Dr. Marco Racanelli will be presenting on May 10, 2017.
The 17th Annual Oppenheimer Israeli Conference will take place at the David Intercontinental Hotel in Tel-Aviv. TowerJazz's CEO, Mr. Russell Ellwanger, will be presenting on May 21, 2017.
The 14th Annual Craig-Hallum Institutional Investor Conference will take place at the Depot Renaissance Minneapolis Hotel in Minneapolis. Dr. Marco Racanelli will be presenting on May 31, 2017.
At all conferences there will be an opportunity for investors to meet one-on-one with management. Interested investors should contact the conference organizers or the Investor Relations team at TowerJazz at [email protected].
About TowerJazz
Tower Semiconductor Ltd. (NASDAQ: TSEM, TASE: TSEM) and its subsidiaries operate collectively under the brand name TowerJazz, the global specialty foundry leader. TowerJazz manufactures next-generation integrated circuits (ICs) in growing markets such as consumer, industrial, automotive, medical and aerospace and defense. TowerJazz's advanced technology is comprised of a broad range of customizable process platforms such as: SiGe, BiCMOS, mixed-signal/CMOS, RF CMOS, CMOS image sensor, integrated power management (BCD and 700V), and MEMS. TowerJazz also provides world-class design enablement for a quick and accurate design cycle as well as Transfer Optimization and development Process Services (TOPS) to IDMs and fabless companies that need to expand capacity. To provide multi-fab sourcing and extended capacity for its customers, TowerJazz operates two manufacturing facilities in Israel (150mm and 200mm), two in the U.S. (200mm) and three facilities in Japan (two 200mm and one 300mm). For more information, please visit www.towerjazz.com.
| Contact: | |
| Tower Semiconductor | GK Investor Relations |
| Noit Levi, +972 4 604 7066 | Gavriel Frohwein, (646) 688 3559 |
| [email protected] | [email protected] |
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/eb1c9011-e2da-4f8e-b59f-06aa21243e63


Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade
Microsoft Restores Microsoft 365 Services After Widespread Outage
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 



